Document is current
Any future updates will be listed below
-
Authors
Velonjara, Julia https://orcid.org/0000-0002-7947-094X
Mills, Brianna
Lujan, Silvia
Petroni, Gustavo
Bell, Michael J.
Guadagnoli, Nahuel
Mock, Charles
Hughes, James P.
Vavilala, Monica S.
Rowhani-Rahbar, Ali
,
Alassia, Mariela
Abalos, Silvina
Gómez Arriola, Natalia
Castellani, Pablo
Chuchuy, Sandra
Cinquegrani, Karina
Dávila, Carlos
Diettes, Adriana
López Cruz, Gabriela
Mansur, Alejandro
Marinelli, Ivana
Medici, Paula
Oliveri, Silvia
Penazzi, Matías
Romero, Graciela
Segado, Ariel
Depetris, Alejandra
Giordano, Daniel
Boyle, Linda Ng
Moore, Megan
Weiner, Bryan
Segar, Karen
Wang, Jin
Deshpande, Shyam J.
Hicks, Chelsea
Graves, Janessa
- License Information
-
More Information
Article History
Received: 14 March 2022
Accepted: 16 November 2022
First Online: 5 December 2022
Declarations
:
: The PEGASUS Argentina study qualified and was approved for expedited review (“minimal risk’; Category 7) through the University of Washington IRB Committee D. The intervention was also approved at the IRBs of each of the local study hospitals in South America. Written consent of patients’ guardian(s) is obtained by study coordinators at enrollment (Additional file), and for recovering patients > 7 years, oral assent is sought before discharge.
: Not applicable; this protocol contains no individual persons’ data.
: The authors declare they have no other competing interests.
